Jove
Visualize
Contact Us

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

755
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
755
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.6K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

752
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
752

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nano alchemy: Ionic liquids transforming metallic particles for medicine.

Drug discovery today·2026
Same author

Advancements in RNA-based therapies from bench to bedside.

npj drug discovery·2026
Same author

Effect of Amblyopia Therapy on Retinal and Choroidal Thickness in Children With Unilateral Anisometropic Amblyopia: A Prospective Longitudinal Study.

Cureus·2026
Same author

Artificial intelligence in multi-omics analysis of small-molecule drug discovery.

Progress in molecular biology and translational science·2026
Same author

Changes in Intraocular Pressure and Ganglion Cell Complex Thickness After Pars Plana Vitrectomy in Patients With and Without Diabetes Mellitus.

Cureus·2026
Same author

Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells.

ACS applied bio materials·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 24, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.4K

Prone-to-aggregate nanoparticle for cancer-targeted drug delivery.

Manisha Choudhary1, Dnyaneshwar Kalyane2, Devendra Choudhary1

  • 1National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, An Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Palaj, Opp. Air Force Station, Gandhinagar-382355, Gujarat, India.

International Journal of Pharmaceutics
|January 22, 2026
PubMed
Summary

Prone-to-aggregate nanoparticles (NPs) can be engineered to aggregate at tumor sites, enhancing cancer treatment efficacy and reducing side effects. This targeted aggregation strategy is key for advanced nanomedicine in oncology.

Keywords:
Cancer therapyProne-to-aggregate NPsReactive oxygen speciesStimuli-responsivepH-sensitivity

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.5K

Related Experiment Videos

Last Updated: Jan 24, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.4K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.5K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Nanoparticles (NPs) are increasingly utilized in diverse cancer management strategies.
  • Their dynamic surface properties enable tailored modifications for specific biomedical applications.
  • Current research prioritizes enhancing NP efficacy through tumor site concentration.

Purpose of the Study:

  • To review the aggregation approach of prone-to-aggregate NPs for selective tumor delivery.
  • To explore various stimuli-responsive triggers for NP aggregation.
  • To discuss the therapeutic and diagnostic applications of this aggregation strategy in cancer therapy.

Main Methods:

  • Review of literature on stimuli-responsive nanoparticle aggregation.
  • Analysis of aggregation triggers including pH, enzymes, redox, temperature, and external fields (magnetic, light).
  • Evaluation of NP applications in drug delivery, imaging, and various cancer therapies.

Main Results:

  • Prone-to-aggregate NPs can achieve targeted accumulation at tumor sites via controlled aggregation.
  • Stimuli-responsive aggregation enhances NP retention and reduces off-target effects.
  • This approach shows promise for improving both diagnostic and therapeutic outcomes in cancer.

Conclusions:

  • The aggregation of prone-to-aggregate NPs is a viable strategy for targeted cancer therapy.
  • Stimuli-responsive aggregation significantly improves NP delivery and efficacy.
  • This approach holds potential for advancing nanomedicine in oncology.